Company Info
Phone(650) 213-8444
Year Established
1999
Ticker
NBIX
Exchange
NASDAQ
Contacts
Anish Bhatnagar, M.D.Chair & CEO
Jim Mackaness
CFO
Kristen Yen, MS
VP, Clinical Operations
Patricia C. Hirano, MPH
VP, Regulatory Affairs
Neil M. Cowen, PhD, MBA
Senior VP, Drug Development
Meredith Manning, M.B.A
CCO
Company Description
Soleno Therapeutics, a Neurocrine Biosciences company, is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
